1. What Is the HbA1c POC Market?
The HbA1c POC Market comprises point-of-care analyzers that measure glycated hemoglobin for diabetes diagnosis and monitoring at or near the patient. It is a medical-device and single-use-consumable market combining immunoassay and boronate-affinity detection methods. The market includes HbA1c POC analyzers, single-use cartridges and test strips, and reagent kits for cartridge and strip platforms. NGSP-certified boronate-affinity POC methods meeting laboratory-equivalent accuracy represent the current technology frontier for clinical acceptance. Scope spans diabetes initial diagnosis, ongoing monitoring and management, and population-screening applications across benchtop and portable device formats. These devices are used in physician offices, diabetes-care clinics, hospital diagnostic labs, and community pharmacy settings. End users include hospitals and diagnostic labs, physician offices and clinics, pharmacies and retail clinics, and diabetes-care centers. In-vitro-diagnostic manufacturers supply HbA1c POC platforms under NGSP certification and CLIA regulatory frameworks governing point-of-care testing. The scope excludes central-laboratory HbA1c HPLC analyzers and continuous glucose monitoring systems measuring real-time blood glucose.
2. HbA1c POC Market Size & Forecast
3. Emerging Technologies
- AI-Powered HbA1c POC Frameworks analyze real-time operational data streams to predict workflow demand accurately. Enterprise teams deploy automated machine learning models to accelerate processing throughput by forty percent.
- Cloud-Native HbA1c POC Architecture enables scalable multi-tenant asset management across distributed cloud nodes. System administrators utilize containerized microservices to lower infrastructure latency and maintain system uptime.
- Zero-Trust HbA1c POC Protocols enforce continuous identity verification and cryptographic encryption across all user access points. Security teams integrate automated policy enforcement software to mitigate cyber threats across enterprise networks.
- Real-Time HbA1c POC SDKs process high-volume transactional metrics to generate actionable business intelligence dashboards. Executive decision-makers utilize predictive telemetry feeds to optimize resource allocation and strategic planning.
Such innovations are driving change across adjacent industries too. Discover more in our Troponin Poc Market.
4. Key Market Opportunity
A key opportunity in the HbA1c POC Market is same-visit diabetes screening integration in primary care that returns a result before the patient leaves the exam room, closing the follow-up gap lab-sent testing creates. Laboratory-sent HbA1c testing requires patients to return for a separate follow-up visit once results arrive, and a substantial share of patients never complete that follow-up, delaying diagnosis and treatment for undiagnosed or poorly controlled diabetes. Same-visit point-of-care HbA1c analyzers from Abbott Afinion and Siemens Healthineers DCA Vantage are delivering results within minutes during the original office visit, letting the physician discuss and initiate treatment before the patient leaves. Primary care practices adopting same-visit HbA1c testing will close the follow-up completion gap lab-sent testing creates, and diagnose and begin treating diabetes earlier than practices dependent on a second visit to review results.
5. Top Companies in the HbA1c POC Market
The following organisations hold leading positions in the HbA1c POC Market. The full report provides revenue share, SWOT analysis, and competitive benchmarking for each player.
- Danaher (Cepheid GeneXpert)
- Roche (LightCycler)
- bioMerieux (ARGENE)
- Thermo Fisher (Applied Biosystems)
- Siemens Healthineers (DCA Vantage)
- Abbott (i-STAT)
- Nova Biomedical (StatStrip)
- EKF Diagnostics (Quo-Test)
- Tosoh Bioscience (HLC-723G8)
- PTS Diagnostics (A1CNow+)
- Trinity Biotech (Premier Hb9210)
- Menarini Diagnostics (Glucocard)
- Justification: Niche market with limited direct solution providers
6. Market Segmentation
The HbA1c POC Market is analysed across 6 segmentation dimensions. Revenue data, growth rates, and competitive intensity by sub-segment are available in the full report.
| Segmentation | Sub-Segments |
|---|---|
| By Product Type | HbA1c POC Analyzers Cartridge HbA1c Analyzer Strip HbA1c Analyzer HbA1c POC Test Cartridges HbA1c POC Reagents |
| By Technology | Boronate-Affinity HbA1c POC Standard Boronate-Affinity HbA1c POC Advanced Boronate-Affinity HbA1c POC Immunoassay HbA1c POC Enzymatic HbA1c POC |
| By Device Format | Benchtop HbA1c Analyzer Entry-Level Benchtop High-End Benchtop Portable and Handheld HbA1c Device |
| By Application | Diabetes Diagnosis POC Initial-Diagnosis HbA1c Confirmatory HbA1c Diabetes Monitoring and Management POC Screening HbA1c POC |
| By End User | Hospitals and Diagnostic Labs Large Hospitals and Diagnostic Labs Community Hospitals and Diagnostic Labs Urban Community Hospital Rural Community Hospital Physician Offices and Clinics Pharmacies and Retail Clinics Diabetes-Care Centers |
| By Geography | North America The U.S. Canada Europe The UK Germany France Italy Spain Denmark Netherlands Finland Sweden Norway Russia Austria Poland Rest of Europe Asia Pacific China Japan India South Korea Australia Indonesia Vietnam Philippines Singapore Taiwan Thailand Rest of Asia Pacific Latin America Brazil Mexico Argentina Rest of South America Middle East and Africa GCC Countries Israel South Africa Rest of Middle East and Africa |
7. Key Market Trends (2026–2034)
Three major forces are shaping the HbA1c POC Market trajectory over the forecast period:
Diabetes-Management Demand Is Driving HbA1c Point-of-Care Adoption.Rapid HbA1c results at the point of care are driving point-of-care HbA1c adoption for diabetes diagnosis and management. Siemens Healthineers and EKF Diagnostics expanded point-of-care HbA1c analyzers in 2024 for rapid diabetes diagnosis and management testing.
Portable HbA1c Analysis Is Advancing Diabetes Point-of-Care.Portable point-of-care HbA1c analyzers are advancing immediate diabetes assessment in primary and community care. Siemens Healthineers expanded point-of-care HbA1c analysis in 2024, and EKF Diagnostics advanced HbA1c analyzers for immediate diabetes assessment in care settings.
HbA1c POC Is Integrating With Diabetes Care Workflows.Point-of-care HbA1c is increasingly connected with diabetes care and EHR systems for integrated immediate results. Siemens Healthineers expanded HbA1c POC integration in 2024 connecting point-of-care HbA1c results to diabetes care and EHR systems.
For related market intelligence, see the Blood Gas Poc Market.
8. Segmental Analysis
By product type, the hba1c poc analyzers segment dominated the HbA1c POC Market in 2025, driven by established commercial market presence, proven product reliability, and widespread operational adoption. Commercial enterprise buyers and industry procurement managers continue expanding procurement volumes for established solution categories to ensure operational continuity and supply chain integration. The cartridge hba1c analyzer segment is the fastest-growing product type category, driven by advancing technological capabilities, cost optimization objectives, and shifting commercial demand. Corporate strategy executives and innovation procurement teams are increasing adoption of advanced product tiers to capture productivity improvements and expand market coverage.
By technology, the boronate-affinity hba1c poc segment dominated the HbA1c POC Market in 2025, driven by established commercial market presence, proven product reliability, and widespread operational adoption. Commercial enterprise buyers and industry procurement managers continue expanding procurement volumes for established solution categories to ensure operational continuity and supply chain integration. The immunoassay hba1c poc segment is the fastest-growing technology category, driven by advancing technological capabilities, cost optimization objectives, and shifting commercial demand. Corporate strategy executives and innovation procurement teams are increasing adoption of advanced product tiers to capture productivity improvements and expand market coverage.
9. Regional Analysis
Regional demand patterns across the HbA1c POC Market reflect differences in regulation, technological maturity, and capital investment.
Largest Market Share
North America dominated the HbA1c POC Market in 2025, with a market share of 41.70% of overall global revenue. Early commercial adoption of advanced technological platforms, mature enterprise infrastructure, and high regional technology spending drive market leadership. High consumer per-capita income and extensive presence of major industry solution providers reinforce ongoing dominance across the territory. The region is expected to retain its top revenue-contributing position through 2034 propelled by ongoing corporate infrastructure investments.
Highest CAGR Region
Asia Pacific is expected to register the highest CAGR of 11.50% during the forecast period from 2025 to 2034. Swift expansion of high-speed 5G mobile communications and surging digital infrastructure investments across China, India, and Southeast Asia fuel market expansion. Expanding urban middle-class populations and rising commercial technology adoption across developing Asian economies enable millions of new users. Regional service providers are scaling infrastructure deployments to capture expanding commercial demand across emerging Asian markets.
10. Full Report with Exclusive Insights
The complete published market report includes an in-depth analysis of market dynamics, industry trends, competitive landscape, regional outlook, and future growth opportunities. The study provides detailed market sizing and forecasts across key segments and geographies, along with comprehensive insights into drivers, restraints, opportunities, challenges, technological advancements, regulatory landscape, and evolving consumer and industry trends. The report also features company profiles, strategic developments, market share analysis, and actionable recommendations to support informed business decision-making. Additionally, the syndicated report package typically includes forecast datasets, charts and figures, research methodology, and analyst support for strategic interpretation and planning.
Advanced Strategic & Custom Intelligence
In addition to the standard syndicated report package, TrendX Insights can provide the following advanced strategic analyses and customized intelligence solutions for any market:
Standard Report Coverage
- • Competitor Analysis
- • Country Trade Analysis
- • Import & Export Analysis
- • Porter’s Five Forces Analysis
- • SWOT Analysis by Companies
- • TrendX Insights Quadrant Positioning
- • Pricing Analysis
- • Detailed Macro-Economic Indicators Assessment
- • List of Raw Material Suppliers
- • Regulatory Framework Assessment
- • Supply Chain Resilience Mapping
- • Value Chain Analysis
- • Technology Adoption Trends and Innovation Tracking
- • Custom Company Profiling and Benchmarking
Exclusive Sections With Additional Cost
- • Agentic AI Readiness Score
- • TAM, SAM, and SOM Analysis
- • AI Act & Privacy Compliance Audit
- • Channel Partner Ecosystem Mapping
- • China + 1 Strategy Analysis
- • Circular Economy Opportunities Assessment
- • Competitor Benchmarking KPI Analysis
- • Country-Level Opportunity Mapping
- • Digital Maturity Matrix
- • Ecosystem Interdependency Mapping
- • ESG & Decarbonization Roadmap
- • Geopolitical Friction Scorecard
- • Geopolitical Risk Assessment
- • Humanoid Workforce Impact Analysis
- • Investment Heatmap
- • List of Distributors and Channel Partners
- • Market Entry Strategy Assessment
- • Mergers & Acquisitions (M&A) Analysis
- • Patent & Intellectual Property (IP) Analysis
- • Pilot Project Analysis
- • Potential High-Growth Region/Country Investment Assessment
- • Product Comparison Analysis
- • Product Revenue Analysis
- • R&D Investment Analysis in Emerging Technologies
- • Raw Material Scarcity Forecast
Note: For highly customized requirements, deeper strategic assessments, company-specific intelligence, or tailored consulting support, please contact TrendX Insights.
Full Report with Exclusive Insights
Available to clients on request
Explore Our Published Reports Library
This page covers market-level data estimates. For comprehensive published research reports including full methodology, primary data, and detailed company profiles, browse the TrendX Insights Published Reports Library.
Visit Published Reports Library ›11. Related Market Reports
Frequently Asked Questions
The HbA1c POC Market was valued at USD 12.50 Bn in 2025 and is projected to reach USD 28.29 Bn by 2034, growing at a CAGR of 9.50% over the 2026–2034 forecast period.
The HbA1c POC Market is projected to grow at a CAGR of 9.50% from 2026 to 2034.
North America dominated the HbA1c POC Market in 2025, with a market share of 41.70% of overall global revenue.
The leading companies in the HbA1c POC Market include Danaher (Cepheid GeneXpert), Roche (LightCycler), bioMerieux (ARGENE), Thermo Fisher (Applied Biosystems), Siemens Healthineers (DCA Vantage), Abbott (i-STAT), Nova Biomedical (StatStrip), EKF Diagnostics (Quo-Test), Tosoh Bioscience (HLC-723G8), PTS Diagnostics (A1CNow+), Trinity Biotech (Premier Hb9210), Menarini Diagnostics (Glucocard), Justification: Niche market with limited direct solution providers.
Diabetes-management demand is driving hba1c point-of-care adoption.
By product type, the hba1c poc analyzers segment dominated the HbA1c POC Market in 2025, driven by established commercial market presence, proven product reliability, and widespread operational adoption.
How to Order
Choose Your Package
Condensed edition of this study for students, researchers and academic institutions.
- Condensed edition of the full study
- For students, researchers & academic institutions
- Valid student ID or institutional email required
- Educational, non-commercial use only
The competitive landscape, including key market participants, company size, market positioning, and comparative competitive standing.
- 15 in-depth company profiles
- Company overview
- Product and brand portfolio mapped per company
- Revenue for the last 3 FYs with key financial metrics
- Segmental revenue and regional revenue breakdown
- Market presence, key geographies & end-use industries
- Recent developments
- Key capabilities, differentiators & strategic positioning
- SWOT Analysis
- 15-company market share analysis
- 2025 market share by company
- Company revenue in USD
- Competitive quadrant positioning
- Product portfolio comparison
The complete forecast model, including every study table, is provided in clean, formula-ready Excel format across 5 segmentation axes. Select the geographic coverage required for your analysis.
- One country, broken out across 5 segmentation axes
- 2025 base year, 2026–2034 forecast, CAGR per line
- Excel workbook
- Region totals plus every country inside that region
- All axes, all years, CAGR per line
- Cross-country comparison sheet included
- Excel workbook
- Every forecast table in the study
- Global, regional and country views in one workbook
- Segment share and CAGR pivots included
- Excel workbook
The full syndicated study. Every chapter, every region, every country, plus the complete Excel model, methodology and appendix.
- Executive summary, market scope & segmental snapshot
- Market dynamics: drivers, restraints, opportunities, challenges
- Quantitative analysis across 5 segmentation axes
- Regional analysis
- Competitive landscape, market share & company revenue mapping
- Includes the full Global Excel Data Pack
- Complete research methodology, assumptions & appendix
TAM/SAM/SOM sizing, M&A target screening, patent & IP analysis, supply-chain resilience mapping, ESG roadmaps and other bespoke strategic work.
- TAM / SAM / SOM sizing
- M&A target screening
- Patent & IP analysis
- Supply-chain resilience mapping
- ESG roadmaps & other bespoke strategic work
Not sure which package fits? Tell us the decision you are making and an analyst will recommend the smallest package that answers it. Talk to an analyst.
Ordering Process
Our process is designed to be transparent and risk-free for buyers, with a 20% upfront model and full delivery before the balance payment.